Nuvation Bio
Develops cancer medicines led by IBTROZI and a focused oncology pipeline.
$6.65
After-hours close−0.01 (−0.15%)
At close$6.66(−4.72%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.12 | — | — |
| Aug 2026 | −$0.14 | −$0.15 | −5.9% |
| May 2026 | $0.12 | $0.01 | −91.7% |
| Mar 2026 | −$0.11 | −$0.11 | 0.0% |
| Nov 2025 | −$0.17 | −$0.16 | +5.9% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Jan 2021 | |||
| Aug 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | −$0.12 | — | — | $35.8M | — | — |
| Aug 6, 2026 | −$0.14 | −$0.15 | −5.9% | $27.0M | $31.7M | +17.2% |
| May 4, 2026 | $0.12 | $0.01 | −91.7% | $66.2M | $83.2M | +25.7% |
| Mar 2, 2026 | −$0.11 | −$0.11 | 0.0% | $37.8M | $41.9M | +10.7% |
| Nov 3, 2025 | −$0.17 | −$0.16 | +5.9% | $36.8M | $13.1M | −64.4% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 6, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 5, 2024 | ||||||
| May 14, 2024 | ||||||
| Feb 29, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 15, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 9, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 12, 2021 | ||||||
| May 17, 2021 | ||||||
| Mar 11, 2021 | ||||||
| Jan 20, 2021 | ||||||
| Aug 14, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
